Suja Life Reports First Quarter 2026 Financial Results
Suja Life (NASDAQ: SUJA) reported first-quarter 2026 net sales of $107.1 million, up 22.5% year over year from $87.4 million. Adjusted EBITDA rose 66.3% to $25.0 million, with margin expanding to 23.4%. Net income was $7.7 million versus a prior-year net loss. The company initiated 2026 guidance: net sales $367–$371 million and Adjusted EBITDA $70–$72 million.
How this was made

The 30-second read
Why it matters
The print highlights accelerating net sales (+22.5% YoY) and a sharp jump in Adjusted EBITDA (+66.3% YoY), alongside gross margin expansion and a shift to positive net income. The FY2026 guidance provides a concrete growth and profitability roadmap (net sales $367–$371M; Adjusted EBITDA $70–$72M).
Market read
Traders can update forward models using the explicit FY2026 ranges and assess whether Q1 margin expansion and EBITDA leverage are sustainable.
What to watch
SG&A as a % of sales rose (35.3% vs 41.3% prior year, but freight increased), and the company notes inability to reconcile forward Adjusted EBITDA to GAAP net income, leaving GAAP earnings visibility limited.
Background
Suja Life began trading on Nasdaq under SUJA on May 7, 2026 and completed its IPO on May 8, 2026; this is its first-quarter post-IPO financial update with an FY2026 outlook.
Ticker impact
Suja Life reports Q1 2026 results and initiates FY2026 outlook, including net sales, Adjusted EBITDA, and full-year guidance.
Likely positive near-term bias as guidance provides a fresh valuation anchor for a newly public name.
The article contains a full Q1 financial print (sales, gross margin, net income, Adjusted EBITDA) plus explicit FY2026 net sales and Adjusted EBITDA ranges, which are direct inputs to forward estimates and positioning.
Market effects
Reinforces demand/read-through for “better-for-you” natural beverage brands with functional benefits and clean ingredients.
No specific regional spillover beyond US retail distribution performance.
Limited; primarily US consumer packaged beverages and domestic distribution.
Counterpoint
Adjusted EBITDA outperformance may be sensitive to promotional intensity, freight costs, and shipment timing rather than durable underlying demand.
Key entities
- public_companySuja Life, Inc.
Reports Q1 2026 financial results and initiates FY2026 outlook; newly public on Nasdaq (SUJA).
- executiveMaria Stipp
CEO quoted on Q1 performance drivers and growth positioning.



